IWILFIN
Drug
USWM, LLC
Total Payments
$343,585
Transactions
247
Doctors
183
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $343,585 | 247 | 183 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $304,709 | 2 | 88.7% |
| Honoraria | $14,960 | 4 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,130 | 5 | 3.2% |
| Food and Beverage | $10,204 | 228 | 3.0% |
| Travel and Lodging | $1,787 | 5 | 0.5% |
| Consulting Fee | $795.00 | 3 | 0.2% |
Payments by Type
Research
$304,709
2 transactions
General
$38,876
245 transactions
Research Studies & Clinical Trials
Top Doctors Receiving Payments for IWILFIN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatric Hematology-Oncology | Charlotte, NC | $317,564 | 14 |
| , DO | Pediatric Hematology-Oncology | Charlotte, NC | $7,004 | 11 |
| , MD | Pediatric Hematology-Oncology | Saint Louis, MO | $3,247 | 3 |
| Unknown | — | Columbus, OH | $3,000 | 1 |
| , MD | Pediatric Hematology-Oncology | Tampa, FL | $2,980 | 2 |
| , NP-C | Family | Sandy, UT | $356.40 | 2 |
| , APRN, CNP | Nurse Practitioner | Bay Village, OH | $341.40 | 2 |
| , CNP | Pediatrics | Akron, OH | $341.40 | 2 |
| , DNP, APRN, CPNP-AC | Acute Care | El Paso, TX | $250.80 | 4 |
| , NP | Family | El Paso, TX | $156.61 | 3 |
| , APRN, BC | Pediatrics | Kansas City, MO | $152.25 | 4 |
| , MD | Pediatrics | Lubbock, TX | $145.00 | 2 |
| , NP | Pediatrics | Palo Alto, CA | $138.69 | 1 |
| , NP | Nurse Practitioner | Belmont, CA | $138.68 | 1 |
| , M.D | Pediatric Hematology-Oncology | El Paso, TX | $138.01 | 2 |
| , MD | Pediatric Hematology-Oncology | Coral Gables, FL | $130.66 | 2 |
| , M.D | Pediatrics | Iowa City, IA | $123.29 | 1 |
| , M.D | Pediatrics | Iowa City, IA | $123.29 | 1 |
| , ARNP | Nurse Practitioner | Iowa City, IA | $123.29 | 1 |
| Kelly Landry | Pediatrics | Atlanta, GA | $119.24 | 1 |
| , CPNP | Pediatrics | Atlanta, GA | $119.24 | 1 |
| , CPNP | Pediatrics | Atlanta, GA | $119.24 | 1 |
| , NP | Pediatrics | Albuquerque, NM | $119.10 | 1 |
| , M.D | Pediatrics | Albuquerque, NM | $119.10 | 1 |
| , M.D | Pediatric Hematology-Oncology | Albuquerque, NM | $119.10 | 1 |
About IWILFIN
IWILFIN is a drug associated with $343,585 in payments to 183 healthcare providers, recorded across 247 transactions in the CMS Open Payments database. The primary manufacturer is USWM, LLC.
Payment data is available from 2024 to 2024. In 2024, $343,585 was paid across 247 transactions to 183 doctors.
The most common payment nature for IWILFIN is "Unspecified" ($304,709, 88.7% of total).
IWILFIN is associated with 2 research studies, including "Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)" ($256,341).